These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 400768)

  • 1. Mechanisms of impaired acute insulin release in adult onset diabetes: studies with isoproterenol and secretin.
    Halter JB; Porte D
    J Clin Endocrinol Metab; 1978 Jun; 46(6):952-60. PubMed ID: 400768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics.
    McRae JR; Metz SA; Robertson RP
    Metabolism; 1981 Nov; 30(11):1065-75. PubMed ID: 7026970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor.
    Robertson RP; Porte D
    J Clin Invest; 1973 Apr; 52(4):870-6. PubMed ID: 4693651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes.
    Sando H; Lee YS; Iwamoto Y; Ikeuchi M; Kosaka K
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1143-9. PubMed ID: 6999008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The augmentation effects of secretin on the insulin responses to known stimuli: specificity for glucose.
    Lerner RL
    J Clin Endocrinol Metab; 1977 Jul; 45(1):1-9. PubMed ID: 874055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine-stimulated acute phase of insulin secretion in non-insulin-dependent diabetes in the young.
    Naidoo C; Jialal I; Joubert SM
    Diabetes Res; 1986 Mar; 3(3):127-9. PubMed ID: 3519045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion.
    Pfeifer MA; Halter JB; Beard JC; Judzewitsch R; Porte D
    Diabetes; 1982 Feb; 31(2):154-9. PubMed ID: 6759232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients.
    Palmer JP; Ensinck JW
    J Clin Endocrinol Metab; 1975 Sep; 41(3):498-503. PubMed ID: 1159058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
    N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological doses of secretin do not stimulate acute insulin release.
    Brodows RG; Chey WY
    J Clin Endocrinol Metab; 1980 Mar; 50(3):603-6. PubMed ID: 6987259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.
    Lerner RL; Porte D
    J Clin Invest; 1972 Jul; 51(7):1624-31. PubMed ID: 4555783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stimulation of insulin secretion in diabetics using secretin].
    Raptis S; Schröder KE; Faulhaber JD; Pfeiffer EF
    Dtsch Med Wochenschr; 1968 Dec; 93(50):2420-4. PubMed ID: 5698974
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
    Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D
    J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretin-induced insulin response. II. Dose-response relation.
    Enk B
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):312-7. PubMed ID: 775874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin response to glucose is lower in individuals homozygous for the Arg 64 variant of the beta-3-adrenergic receptor.
    Walston J; Silver K; Hilfiker H; Andersen RE; Seibert M; Beamer B; Roth J; Poehlman E; Shuldiner AR
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4019-22. PubMed ID: 11095426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased insulin sensitivity and decreased insulin secretion in offspring of insulin-sensitive type 2 diabetic patients.
    Matsumoto K; Sakamaki H; Izumino K; Yano M; Ueki Y; Miyake S; Tominaga Y
    Metabolism; 2000 Sep; 49(9):1219-23. PubMed ID: 11016908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucose tolerance and insulin secretion in relation to age in type-II diabetes--a contribution to the pathogenesis of type-II diabetes mellitus].
    Verlohren HJ; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(2):77-8. PubMed ID: 6383778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.